After liver transplantation a few patients develop fulminant liver failure of sudden onset and uncertain aetiology. Previously reported cases describe a picture of massive graft necrosis without specific features, and a variety of possible aetiologies including ischaemia, infection, and rejection have been proposed. '3 We present six such cases with distinctive clinical and pathological features which seem to comprise a specific syndrome.
Material and methods
The patients' notes, including surgical records, anaesthetic details, and treatment charts were reviewed in detail. Some of the main clinical details are summarised in table 1. For cases 2, 3, and 4 the initial immunosuppression was intravenous azathioprine (2 mg/kg/day) and hydrocortisone (200 mg/day adult dose, 50 mg/day child dose). Case I was given intravenous cyclosporin 5 mg/kg/day. Cases 5 and 6 received both azathioprine and cyclosporin. When stable, cases 1, 2, 4, and 5 were converted to oral cyclosporin (10 mg/kg/day) plus oral prednisolone (20 mg/day adult dose, 5 mg/day child dose). The Accepted for publication 3 November 1988 intake of cyclosporin was adjusted to achieve whole blood trough concentrations of 400-750 ig/l as measured by radioimmunoassay with polyclonal antibody (Sandoz). Episodes of acute rejection were treated with high dose steroids (200 mg oral prednisolone or 1 g intravenous methyl prednisolone for three consecutive days) in addition to the usual immunosuppressive regimen.
Needle biopsy of the donor liver was carried out immediately following its insertion as a baseline assessment in five patients (cases 1, 2, 4, 5, 6). Eight post-transplant biopsy specimens (seven needle, one wedge), four livers removed surgically at retransplantation, and two necropsy livers were also examined. All post-transplant biopsy material was obtained when there was clinical and biochemical evidence of graft failure and with the informed consent of the patients or their relatives. Necropsy specimens were obtained at 16 hours in case 3 and 20 hours in case 4 .
Tissues were fixed in formalin and embedded in paraffin wax. Sections from each case were stained Died day 20-disseminated aspergillosis a-l -AT = a-I -antitrypsin deficiency. 5, 4 , and 3, respectively). Cases 1, 4, and 5 had early episodes of acute rejection, confirmed histologically (see below). These were treated with high dose steroids which resulted in a good clinical response. All six patients died. Cases 3 and 4 died before retransplantation could be carried out. The others were retransplanted, two dying from infection (cases 1 and 6) and two from bleeding (cases 2 and 5).
OTHER LABORATORY FINDINGS
Sudden onset of liver failure was characterised biochemically by a rapid increase in serum aspartate transaminase activity (median 7-5 x baseline values, range 3-14 x). Bilirubin concentrations remained unchanged or were only slightly increased. A typical biochemical profile is summarised in fig 1 (case 1) .
Liver failure was also associated with a rapid increase in prothrombin time (median 4 x baseline values, range 2-8 x ) (fig 1) . In case 6 there was a sudden fall in platelets (210 on day 3, 30 on day 4). The other cases showed no clinically important change in platelet counts, although these were persistently low in three. Other variables of clotting function (fibrin, fibrin degradation products) were not assessed.
Case 3 received an ABO incompatible graft (donor A negative, recipient 0 positive). The other patients were matched for blood group but not HLA type. None of the patients had detectable cytotoxic antibodies before surgery. Four had repeat assays at one week which were negative again in two (cases 4 Clinically important bacterial infection occurred in only one patient (case 4), who developed an enterobacter urinary tract infection with septicaemia. This occurred 10 days before onset of liver failure and was successfully treated with antibiotics.
All six patients had patent hepatic arteries on angiography.
PATHOLOGICAL FINDINGS
Peroperative ("time zero") biopsy specimen All five biopsy specimens contained sinusoidal aggregates of neutrophil polymorphs consistent with surgical trauma. Four (cases 1, 2, 4, and 5) showed a mild degree of fine cytoplasmic vacuolation in hepatocytes, two (cases 2 and 6) contained occasional small foci ofhepatocyte necrosis and two showed mild cholestasis. These changes were most pronounced in perivenular hepatocytes.
Overall, the findings in these specimens did not differ significantly from those obtained peroperatively from other cases during the same period.
Early postoperative biopsy specimens: acute rejection Three cases (1, 4, and 5) had early biopsies (all day 6) showing features of acute rejection as previously described elsewhere.4 Briefly, these comprised: (i) a mixed portal inflammatory infiltrate; (ii) inflammatory cells, especially polymorphs, surrounding and infiltrating bile ducts; (iii) a variable degree of portal and hepatic venular endothelial inflammation. One biopsy specimen (case 4) showed narrow zones of centrilobular haemorrhage and hepatocyte lossthese lesions were not present in the other two biopsy specimens. Case 5 had a further biopsy after treatment (day 12). This showed resolving portal inflammation, again without evidence of centrilobular haemorrhage or necrosis. 1 Haemorrhage and hepatocyte necrosis The most striking feature seen in all cases was that of massive haemorrhage and hepatocyte necrosis. Macroscopically this resulted in generalised swelling, congestion, and softening of the graft. The mean weight of the end stage livers was 2000 g (range 1560-2200 g). Histologically haemorrhage and necrosis were generally most severe in acinar zones 2 and 3 but also had a pan-acinar distribution in many places (fig 2) . Hepatocyte necrosis had a mainly coagulative pattern and at least 50% ofhepatocytes were destroyed by this process in the end stage livers. In two cases (3 and 4) serial histological material was available for comparison. This showed a haemorrhagic lesion initially confined to perivenular areas with early disruption of liver cell plates (fig 3) . At necropsy this lesion had progressed to a pan-acinar distribution with virtually no remaining hepatocytes.
A light mixed inflammatory infiltrate composed of neutrophil polymorphs, lymphocytes, plasma cells and macrophages was usually present in areas of haemorrhagic necrosis. Inflammatory changes were not severe in any of these cases. No viral inclusions were seen histologically and no organisms were shown by Gram staining.
In the earlier and milder lesions portal tracts were generally spared. In the end stage livers there were many areas of haemorrhage into portal tracts associated with necrosis of portal structures. In all cases there was damage to the donor gallbladder conduit: this ranged from a mild focal lesion to transmural haemorrhagic necrosis (fig 4) . Inflammatory changes were again relatively minor in these areas.
2 Portal inflammation and bile duct damage Two cases (4 and 5) showed evidence of persistent or recurrent portal inflammation in needle biopsy specimens associated with progressive loss of small bile ducts (fig 5) . In the first case bile duct loss was severe with 90% of small portal tracts being devoid of any recognisable bile ducts by the time 6) . In both cases this lesion was associated with loss of small bile ducts. Inflammatory changes were seen around and within the wall of some of these vessels-these lesions were rare, mild, and not associated with frank necrotising damage, Another case (case 1) showed fibrinoid necrosis in the wall of one medium sized artery and occlusive thrombi-in two other medium sized vessels.
Smaller arteries and arterioles, unless destroyed by haemorrhagic necrosis, were always normal and showed no evidence of thrombosis or inflammation. 4 Hepatic vein lesions The main hepatic vein bran- Acute rejection In addition to the characteristic portal changes described earlier, several biopsy specimens in this group showed small foci of perivenular hepatocyte loss and congestion. These changes were mild and reversible in cases responding to additional immunosuppression. Four cases showed a loss of bile ducts in association with or following an episode of severe acute cellular rejection. These also returned to normal numbers following additional immunosuppression.5 Most of the biopsy specimens in this group were obtained in the early period (day 5-15) after surgery. Most of the specimens in this group were obtained at a later date than cases of massive haemorrhagic necrosis. The median graft survival with chronic rejection was five months. Three cases, however, showed a significant loss of bile ducts within four weeks of transplantation-an "acute vanishing bile duct syndrome"! Ischaemia/infarction These cases were characterised by areas ofcoagulative hepatocyte necrosis9 accompanied by varying degrees of inflammatory infiltration. Focal congestion was commonly present but a diffuse haemorrhagic lesion was not seen in any ofthese cases. An underlying cause for ischaemia was identified in 14 of 17 cases: Eight had technical problems with transplantation, complicated by bleeding and hypotension; three had hepatic artery thrombosis; one had inferior vena caval thrombosis causing an acute Budd-Chiari syndrome; one had a donor liver with very small vessels which were thought inadequate for proper perfusion and one had persistent postoperative hypotension probably related to cardiac dysfunction caused by opportunistic fungal infection. In three cases no adequate cause for ischaemia was found. One of these had multiple subcapsular infarcts at necropsy. Another had a needle biopsy specimen showing recent infarction with 368 a neutrophil infiltrate-subsequent biopsy specimens showed no evidence of ischaemia and this patient was alive and well with stable graft function at the time of writing. The remaining case had a biopsy specimen showing haemorrhagic infarction. This patient had severe cerebral complications and died as a result. Necropsy was not carried out. Fifteen cases in this group died with a median survival of 16 days.
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Discussion
The six cases described here all have a similar mode of clinical presentation and characteristic pathological changes in which the main feature is that of massive haemorrhagic graft necrosis. These features are sufficiently distinctive and different from other recognised patterns of graft damage to suggest that they constitute a specific post-transplant syndrome.
Previous accounts of liver allograft pathology describe occasional cases of fulminant liver failure of uncertain aetiology occurring in the early postoperative period.'30' Pathological details are generally lacking in previous reports, making direct comparison with our cases difficult. Nevertheless, all of these most probably represent the same or a closely related phenomenon. The mechanisms underlying this process of acute graft failure are poorly understood. Several possible aetiologies have been suggested but, as yet, none has been conclusively confirmed.
An ischaemic aetiology, possibly related to hepatic arterial kinking, was first suggested by Starzl et al " but there has been no further radiological evidence to support this hypothesis. An ischaemic component cannot be ruled out, particularly in view of the predominantly coagulative pattern of necrosis present, but the overall pattern of damage seen in our cases of massive haemorrhagic necrosis differs from that seen in ischaemic damage due to hypotension or hepatic artery thrombosis. Haemorrhage is not present to the same extent in the latter cases.
The presence of large numbers of Gram negative bacilli both in necrotic liver and peripheral blood in some of these cases2"0 raises the possibility of an infective aetiology. Studies in dogs, however, suggest that bacterial colonisation is probably a secondary event in an already damaged liver rather than the primary cause of graft necrosis.'2 None of our cases had any evidence of infection in blood or bile cultures and Gram staining in liver sections was uniformly negative.
Several viruses occasionally cause fulminant hepatitis in immunocompromised patients. Herpes simplex, zoster, and adenovirus have all been described as causes ofmassive hepatic necrosis. '>" Liver failure in these cases usually occurs as part of a spectrum of lesions caused by disseminated viral Hubscher, Adams, Buckels, McMaster, Neuberger, Elias infection. None of our cases had any features suggestive of viral infection, either clinically, or in the liver and other organs at necropsy. Massive haemorrhagic necrosis with a relatively minor cellular component is also described in some cases of neonatal and infantile enterovirus infection. '8 19 The possibility of uncontrolled rejection as a cause for fulminant liver failure was first suggested by Starzl et al, who described three cases of so-called "rejection crisis".'" Although three of our cases had early episodes of acute rejection, all responded initially to high dose steroids and none of the later biopsy specimens or end stage livers showed the typical features of acute cellular rejection.342' 22 In particular, the paucity ofcellular infiltration within necrotic areas offers evidence against a cell mediated immunological reaction.
Massive haemorrhagic necrosis with only minimal cellular infiltration has recently been described in an animal model of hyperacute humoral-mediated rejection.23 Hyperacute rejection is not well documented in human liver allografts although one case was reported by Snover.2' Although hyperacute rejection is an attractive hypothesis for our cases of massive graft necrosis, the mode of presentation is not in keeping with hyperactue rejection as described in other organs; all of our cases had a clear interval of stable graft function of at least three days before onset of sudden graft failure. The importance of ABO incompatibility in case 3 is uncertain. Although this patient sustained an earlier deterioration clinically, the histological features were indistinguishable from the other five who were ABO identical or compatible. An improved survival in patients receiving ABO identical grafts, when compared with non-identical grafts, has recently been reported in a large series of 520 patients. 25 The reasons for this are unclear and there is no evidence that poor survival in the latter group is related to problems with rejection. No examples of hyperacute rejection were reported in any of these cases.
The possibility of a "single organ" Schwartzmann reaction as a cause for massive graft necrosis has been suggested by Portmann et al,' who describe one case with a histological picture of haemorrhagic infarction associated with the presence oflarge numbers ofGram negative bacilli and sinusoidal deposits of fibrin. A similar lesion has been produced experimentally in the liver ofrabbits by a Schwartzmann mechanism using E coli26 and viral reagents, adenovirus, and hepatitis B surface antigen. 27 Although the main pathological feature that characterises this syndrome is massive haemorrhagic necrosis, the presence of other lesions related to blood vessels and bile ducts in five of the six cases described here suggests that there may be some overlap with other forms of graft damage. Two of our cases showed evidence of bile duct loss and foam cell arteriopathy-the lesions which characterise chronic rejection of the liver allograft and the vanishing bile duct syndrome (VBDS).'289 Furthermore, small areas of perivenular hepatocyte necrosis and congestion or haemorrhage are seen in acute cellular rejection, acute VBDS, and chronic rejection. 38 In acute rejection these lesions are reversible and do not progress in most cases. In chronic rejection the lesions are gradually replaced by fibrous tissue. Membranous expression of HLA class I antigens has been observed in perivenular hepatocytes in rejecting liver allografts, W34 and we have recently described a pan-acinar pattern of membranous class I antigen display in some cases of massive haemorrhagic necrosis. 4 These observations suggest that there may be a common underlying mechanism for cases of massive haemorrhagic necrosis and other forms of graft damage with different components of the liver being affected to a greater or lesser degree in different cases. Recent studies have implicated humoral mechanisms as the cause of damage to bile ducts35 and vascular endothelium" in cases of chronic rejection, and these findings would further support a unifying mechanism of humoral-mediated graft damage.
The clinical implication of veno-obliterative lesions in four of six cases described here is uncertain. In places the pattern of loose intimal fibrosis resembles the changes seen in acute veno-occlusive disease of the liver due to drugs and other toxic agents.37 Azathioprine has been described as a cause of hepatic venoocclusive disease following renal transplantation3839 and was used in three of the four patients who developed veno-obliterative lesions. Elsewhere the picture more closely resembles a severe form of rejection endotheliitis. The difficulty in distinguishing between these two possible causes for veno-occlusive lesions was also seen in a case ofacute VBDS described recently by Ludwig et al.8 Although a primary venoocclusive lesion possibly related to immunosuppressive treatment cannot be entirely ruled out, the absence of any hepatic vein lesion in two of our cases with otherwise typical haemorrhagic necrosis and the presence of fairly mild lesions in another two cases makes this unlikely to be the only mechanism involved. A more likely explanation is that venoocclusive lesions are a secondary event occurring as a result of perivenular ischaemic injury. Indeed, a similar mechanism has been proposed for the pathogenesis of toxic veno-occlusive disease in man and animals,404' and secondary veno-occlusive lesions are increasingly recognised in a variety of chronic liver diseases including alcoholic hepatitis, primary biliary cirrhosis, and other forms of cirrhosis. 42-" Further studies are clearly required to elucidate the precise mechanisms underlying this severe complication of liver transplantation. More than one aetiological factor may play a part and haemorrhagic graft necrosis may represent the end stage of several different insults to the liver. Nevertheless, the changes described in the six cases presented here seem sufficiently distinctive to regard this as a specific posttransplant syndrome. Until the aetiology is elucidated we suggest that the term "massive haemorrhagic necrosis" be used to described future cases. This term is descriptively accurate and avoids potentially misleading inferences concerning underlying mechanisms.
